Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11212229rdf:typepubmed:Citationlld:pubmed
pubmed-article:11212229lifeskim:mentionsumls-concept:C0026948lld:lifeskim
pubmed-article:11212229lifeskim:mentionsumls-concept:C0079773lld:lifeskim
pubmed-article:11212229lifeskim:mentionsumls-concept:C0167627lld:lifeskim
pubmed-article:11212229lifeskim:mentionsumls-concept:C1539081lld:lifeskim
pubmed-article:11212229pubmed:issue2lld:pubmed
pubmed-article:11212229pubmed:dateCreated2001-2-9lld:pubmed
pubmed-article:11212229pubmed:abstractTextMicroarray analysis is a promising new approach for creating specific expression profiles of multiple genes simultaneously. We quantitatively analyzed differential gene expression patterns in mycosis fungoides-derived clonal T cells and autologous, identically cultured CD4+ lymphocytes using microarrays containing 588 cDNA segments from genes relevant to cell signaling, carcinogenesis, and apoptosis. Among other dissimilarities, neoplastic T cells showed coexpression of CD40 (Bp50) and CD40 ligand (gp39, CD154). These results could be corroborated by reverse transcription-PCR, immunohistochemistry, and two-color immunofluorescence staining. Our data suggest that in cutaneous T-cell lymphoma, CD40/CD40 ligand interactions might represent a paracrine loop that is crucial not only in preventing apoptosis or positively regulating growth but also in homing of neoplastic cells to the skin.lld:pubmed
pubmed-article:11212229pubmed:languageenglld:pubmed
pubmed-article:11212229pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11212229pubmed:citationSubsetIMlld:pubmed
pubmed-article:11212229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11212229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11212229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11212229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11212229pubmed:statusMEDLINElld:pubmed
pubmed-article:11212229pubmed:monthJanlld:pubmed
pubmed-article:11212229pubmed:issn0008-5472lld:pubmed
pubmed-article:11212229pubmed:authorpubmed-author:AVISK EKElld:pubmed
pubmed-article:11212229pubmed:authorpubmed-author:DummerRRlld:pubmed
pubmed-article:11212229pubmed:authorpubmed-author:HäffnerA CAClld:pubmed
pubmed-article:11212229pubmed:authorpubmed-author:StormRRlld:pubmed
pubmed-article:11212229pubmed:authorpubmed-author:ZepterKKlld:pubmed
pubmed-article:11212229pubmed:authorpubmed-author:KamarashevJJlld:pubmed
pubmed-article:11212229pubmed:issnTypePrintlld:pubmed
pubmed-article:11212229pubmed:day15lld:pubmed
pubmed-article:11212229pubmed:volume61lld:pubmed
pubmed-article:11212229pubmed:ownerNLMlld:pubmed
pubmed-article:11212229pubmed:authorsCompleteYlld:pubmed
pubmed-article:11212229pubmed:pagination452-4lld:pubmed
pubmed-article:11212229pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:meshHeadingpubmed-meshheading:11212229...lld:pubmed
pubmed-article:11212229pubmed:year2001lld:pubmed
pubmed-article:11212229pubmed:articleTitleCoexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides).lld:pubmed
pubmed-article:11212229pubmed:affiliationDepartment of Dermatology, University Hospital of Zurich, Switzerland.lld:pubmed
pubmed-article:11212229pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11212229pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11212229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11212229lld:pubmed